The international demand for antimicrobial drugs as commodities is steadily increasing. This pattern can be connected to a number of factors, such as the rapid spread of resistant bacteria and the expanding population in emerging countries. The healthcare industry is reacting to this challenge by raising production and researching new medicines. H